Chagas Disease in the United States: A Perspective on Diagnostic Testing Limitations and Next Steps

Natasha S Hochberg1,2,3, Alyse Wheelock1,3, Davidson H Hamer1,3,4

  • 11Department of Medicine, Section of Infectious Diseases, Boston University School of Medicine, Boston, Massachusetts.

Insights

Chagas disease, a neglected tropical illness, impacts 300,000 in the US. This review highlights diagnostic hurdles and suggests improvements for better Chagas disease detection and management.

Area of Science:

  • Neglected tropical diseases
  • Infectious disease epidemiology
  • Public health

Background:

  • Chagas disease is a significant public health concern in the United States, affecting an estimated 300,000 individuals.
  • It is a neglected tropical disease (NTD) with serious health implications if left undiagnosed and untreated.

Purpose of the Study:

  • To review the current diagnostic challenges associated with Chagas disease in the US.
  • To propose actionable strategies and next steps to overcome these diagnostic shortfalls.

Main Methods:

  • This is a perspective piece, relying on a review of existing literature and expert opinion.
  • Analysis of current diagnostic paradigms and identification of key barriers.

Main Results:

  • Significant challenges exist in the timely and accurate diagnosis of Chagas disease.
  • Current diagnostic approaches may not be adequately addressing the needs of the affected population in the US.

Conclusions:

  • Addressing the diagnostic shortfalls is crucial for improving patient outcomes and disease control.
  • Implementation of proposed strategies is necessary to enhance Chagas disease diagnosis and care in the United States.